Skip to main content
Erschienen in: Journal of NeuroVirology 4/2023

19.05.2023

Cognitive deficits in HTLV-1 patients

verfasst von: Maedeh Kamrani, Sima Saryazdi, Fariba Zemorshidi, Majid Khadem-Rezaiyan, Ghazal Behravan

Erschienen in: Journal of NeuroVirology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus known to be associated with adult T-cell lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Previous researches and brain imaging techniques have suggested cognitive abnormalities as well as brain damage in individuals infected with this virus. Given the insufficient amount of studies on how this virus can impact the affected person’s cognition, we aimed to assess and compare the cognitive abnormalities of HAM/TSP patients, asymptomatic HTLV-1 carriers, and healthy controls. This cross-sectional study was conducted on 51 patients divided into 3 groups; a group of HAM/TSP patients, a group of asymptomatic HTLV-1 carriers, and an uninfected control group. Each group contained 17 members. The cognitive state of the studied population was assessed using the Mini-Mental State Exam (MMSE), Symbol Digit Modalities Test (SDMT), Rey–Osterrieth complex figure test (ROCF), the “Verbal Fluency Test” and the “Trail Making Test” (TMT) components of the Delis–Kaplan executive function system (D-KEFS) test, the Rey Auditory Verbal Learning Test (RAVLT), and digit span memory test. Patients diagnosed with HAM/TSP received significantly lower scores on the SDMT, ROCF, TMT, RAVLT, digit span memory test, and the orientation, calculation, and recall component of the MMSE assessment (p-value < 0.001). In addition, the asymptomatic HTLV-1 carriers obtained lower scores on the SDMT, ROCF, digit span memory test, and the orientation, calculation, and recall component of the MMSE assessment compared to the control group (p-value < 0.001). Overall, the findings suggest that HAM/TSP, or an asymptomatic infection with HTLV-1 could lead to cognitive deficits in the affected individuals. This can further emphasize the importance of assessing the cognitive function and psychiatric abnormalities of those infected with this virus.
Literatur
Zurück zum Zitat Bellini M, Bruschi C, Babini P et al (1994) Diagnosi psichiatrica di depressione maggiore in soggetti con infezione HIV [Diagnosis of major depression in HIV-infected patients]. Minerva Psichiatr 35(3):129–138PubMed Bellini M, Bruschi C, Babini P et al (1994) Diagnosi psichiatrica di depressione maggiore in soggetti con infezione HIV [Diagnosis of major depression in HIV-infected patients]. Minerva Psichiatr 35(3):129–138PubMed
Zurück zum Zitat Cartier L, Gormaz A, Kleinsteuber K, Ramírez E, Galeno H (1997) New form of subcortical dementia: encephalopathy due to infection with human lymphotropic T virus (HTLV-1). Clinical case. Rev Med Chile 125(2):209–213. PMID: 9430942PubMed Cartier L, Gormaz A, Kleinsteuber K, Ramírez E, Galeno H (1997) New form of subcortical dementia: encephalopathy due to infection with human lymphotropic T virus (HTLV-1). Clinical case. Rev Med Chile 125(2):209–213. PMID: 9430942PubMed
Zurück zum Zitat Fullerton C, Florenzano R, Acuna J (2000) Comorbidity of chronic diseases and psychiatric disorders among patients attending public primary care. Rev Med Chile 128(7):729. PMID: 11050833 Fullerton C, Florenzano R, Acuna J (2000) Comorbidity of chronic diseases and psychiatric disorders among patients attending public primary care. Rev Med Chile 128(7):729. PMID: 11050833
Zurück zum Zitat Kira JI, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y (1991) Increased HTLV-I proviral DNA in HTLV-I–associated myelopathy: a quantitative polymerase chain reaction study. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 29(2):194–201. https://doi.org/10.1002/ana.410290214. PMID: 2012389CrossRef Kira JI, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y (1991) Increased HTLV-I proviral DNA in HTLV-I–associated myelopathy: a quantitative polymerase chain reaction study. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 29(2):194–201. https://​doi.​org/​10.​1002/​ana.​410290214. PMID: 2012389CrossRef
Zurück zum Zitat Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, Sohgandi L, Azarpazhooh MR, Rezaee SA, Farid R, Bazarbachi A (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52(3):172–6 https://doi.org/10.1016/j.jcv.2011.07.004. PMID: 21840754 Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, Sohgandi L, Azarpazhooh MR, Rezaee SA, Farid R, Bazarbachi A (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52(3):172–6 https://​doi.​org/​10.​1016/​j.​jcv.​2011.​07.​004. PMID: 21840754
Zurück zum Zitat Rezaei SA, Valizadeh N (2009) Virology of HTLV-1. In: Etemadi M, Faridhosseini R, Rezaee SA, Boostani R (eds) HTLV-1 and associated diseases, 1st edn. Mashhad university of Medical Sciences, Mashhad, pp. 93–126.&nbsp;(Persian) Rezaei SA, Valizadeh N (2009) Virology of HTLV-1. In: Etemadi M, Faridhosseini R, Rezaee SA, Boostani R (eds) HTLV-1 and associated diseases, 1st edn. Mashhad university of Medical Sciences, Mashhad, pp. 93–126.&nbsp;(Persian)
Zurück zum Zitat Shoeibi A, Rafatpanah H, Azarpazhooh A, Mokhber N, Hedayati-Moghaddam MR, Amiri A, Hashemi P, Foroghipour M, Hoseini RF, Bazarbachi A, Azarpazhooh MR (2013) Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran. Acta Neurol Belg 113(4):427–433. https://doi.org/10.1007/s13760-013-0194-6. (Epub 2013 Apr 9 PMID: 23568138)CrossRefPubMed Shoeibi A, Rafatpanah H, Azarpazhooh A, Mokhber N, Hedayati-Moghaddam MR, Amiri A, Hashemi P, Foroghipour M, Hoseini RF, Bazarbachi A, Azarpazhooh MR (2013) Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran. Acta Neurol Belg 113(4):427–433. https://​doi.​org/​10.​1007/​s13760-013-0194-6. (Epub 2013 Apr 9 PMID: 23568138)CrossRefPubMed
Zurück zum Zitat Shunk AW, Davis AS, Dean RS (2006) TEST REVIEW: Dean C. Delis, Edith Kaplan & Joel H. Kramer, Delis Kaplan Executive Function System (D-KEFS), The Psychological Corporation, San Antonio, TX, 2001. $415.00 (complete kit). Appl Neuropsychol 13(4):275–27. https://doi.org/10.1207/s15324826an1304_9 Shunk AW, Davis AS, Dean RS (2006) TEST REVIEW: Dean C. Delis, Edith Kaplan & Joel H. Kramer, Delis Kaplan Executive Function System (D-KEFS), The Psychological Corporation, San Antonio, TX, 2001. $415.00 (complete kit). Appl Neuropsychol 13(4):275–27. https://​doi.​org/​10.​1207/​s15324826an1304_​9
Metadaten
Titel
Cognitive deficits in HTLV-1 patients
verfasst von
Maedeh Kamrani
Sima Saryazdi
Fariba Zemorshidi
Majid Khadem-Rezaiyan
Ghazal Behravan
Publikationsdatum
19.05.2023
Verlag
Springer International Publishing
Erschienen in
Journal of NeuroVirology / Ausgabe 4/2023
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-023-01139-x

Weitere Artikel der Ausgabe 4/2023

Journal of NeuroVirology 4/2023 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.